Issue: February 2014
February 01, 2014
2 min read

THA revision stem shows good osteointegration at 5 years

Issue: February 2014
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Use of a long, tapered hydroxyapatite-coated femoral stem during revision total hip arthroplasty achieved stable fixation and preserved bone stock at 5-years follow-up, according to a recently published study.

“In patients with good bone stock, this type of stem is a reasonable option because it is not only reliable, but also bone preserving,” Gwo-Chin Lee, MD, told Orthopedics Today. “Of the three failures in this series, only one prosthesis was revised for subsidence.”

Lee and colleagues retrospectively reviewed 23 men and 18 women who underwent revision total hip arthroplasty (THA) performed by a single surgeon using the KAR stem (DePuy; Warsaw, Ind.). Thirty patients were revised for aseptic loosening; 10 patients were revised for infection and one patient was revised for dislocation. Twenty-three patients underwent both acetabular and femoral revision. At the time of the revision, 24 patients had Paprosky type I femurs, 14 patients were classified as having type II femurs and three patients had type IIIA femurs. The mean femoral component length was 207 mm, and average femoral cross-sectional diameter was 16 mm. The patients had an average age of 62 years and had an average follow-up of 63 months.

The patients had an average Harris Hip Score of 71 at final follow-up. About half of the patients reported mild hip pain with activity, and 12 patients reported they had no hip pain. During the follow-up, one prosthesis was revised for infection and another patient was revised for aseptic loosening at 15 months. Another patient underwent a subsequent revision for a symptomatic limb length discrepancy caused by component subsidence at final follow-up, Lee said.

Overall, the researchers deemed the implants well-fixed, with no radiolucent lines, good osteointegration and no radiographic evidence of proximal femoral resorption or stress shielding at final follow-up.

Lee noted the prosthesis was not appropriate for patients with severe bone loss.

“The KAR stem is used in Europe, but there is little experience with it in the United States,” Lee said. “It is important to realize that for many of these patients, this revision may not be their last, and maximizing residual bone stock should be considered when choosing implants. Particularly, when the most common type of hip stem currently in use is a blade-type stem, some revisions may not require the aggressive bone reaming that is required with the more traditional type of revision femoral components. This type of revision stem geometry can reliably achieve implant stability while maintaining bone stock.”

He added, “We plan to further define the indications of when to use this type of stem compared to more traditional revision stems.” – by Renee Blisard Buddle

Makani A. J Arthroplasty. 2013;doi: 10.1016/j.arth.2013.08.018.
For more information:
Gwo-Chin Lee, MD, can be reached at the University of Pennsylvania, 1 Cupp Pavilion, 39th and Market Streets, Philadelphia, PA 19106; email:
Disclosure: Lee is on the speakers bureau for DePuy Orthopaedics.